Literature DB >> 7054034

Lymphoreticular malignancy presenting as fulminant hepatic disease.

T V Colby, D R LaBrecque.   

Abstract

Four cases of fulminant hepatic disease caused by lymphoreticular infiltration are described. All 4 patients died within a few weeks and clinical diagnoses included viral hepatitis, alcoholic hepatitis, and drug hepatitis. A diagnosis of malignancy was made prior to autopsy in only 1 of the 4 patients. Autopsies revealed typical malignant histiocytosis in 3 patients and the fourth had a primitive lymphoreticular malignancy with malignant histiocytosis the favored diagnosis. The extent of the liver infiltrate as judged histologically was mild compared with the severe clinical illness. Randomly scattered foci of necrosis associated with the malignant infiltrate were seen in the 2 patients who had marked elevations of serum glutamic oxaloacetic transaminase.

Entities:  

Mesh:

Year:  1982        PMID: 7054034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  4 in total

1.  Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy.

Authors:  Yasser M Bhat; Alyssa Krasinskas; Fiona E Craig; Thomas A Shaw-Stiffel
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases.

Authors:  D Rowbotham; J Wendon; R Williams
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

Review 3.  Acute liver failure due to hepatic involvement by hematologic malignancy.

Authors:  T M Shehab; M S Kaminski; A S Lok
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 4.  Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation.

Authors:  G M Woolf; L M Petrovic; S E Rojter; F G Villamil; L Makowka; L G Podesta; L S Sher; L Memsic; J M Vierling
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.